Cognition Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M Cash from investing activities -58 K-30 K——— — Cash from financing activities 329 K11.38 M1.3 M752 K33.92 M 47.35 M Free cash flow -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M

News

Cognition Therapeutics, Lewy cisimcikli demans ilacı için FDA ile görüştü

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

Cognition’ın DLB ilacı faz 2 çalışmasında olumlu sonuçlar gösterdi

Cognition’s DLB drug shows positive results in phase 2 trial

Cognition Therapeutics genişletilmiş erişim programında hasta kaydını tamamladı

Cognition Therapeutics completes enrollment in expanded access program

Cognition Therapeutics, Alzheimer hastalığı ilacı için Faz 3 planlarını açıkladı

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

Cognition Therapeutics, Alzheimer ilacı denemesi için hasta kaydını tamamladı

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?